OIG found that State Medicaid agencies lack either the policies or the information that they need to oversee reimbursements for drugs purchased under the 340B Drug Discount Program to safety-net organizations, such as community health centers, critical access hospitals, and children’s hospitals.
I do so enjoy it, each and every time, when the OIG comes out with a published findings report endorsing my claims of Medicaid fraud in child welfare.
Thank you, Danny!
HHS OIG Review of State Medicaid Policies and Oversight Activities Related to 340B-Purchased Drugs
No comments:
Post a Comment